Antonio C. Wolff, MD, FACP, FASCO
Antonio C. Wolff, MD, FACP, FASCO
Professor of Oncology, Johns Hopkins University
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
AC Wolff, ME Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ...
J clin oncol 25 (1), 118-145, 2007
5311*2007
College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ...
J Clin Oncol 28 (16), 2784-2795, 2010
4096*2010
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice …
AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ...
Archives of Pathology and Laboratory Medicine 138 (2), 241-256, 2014
35042014
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer
GH Lyman, AE Giuliano, MR Somerfield, AB Benson, DC Bodurka, ...
Journal of clinical oncology 23 (30), 7703-7720, 2005
19692005
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline
TJ Smith, J Khatcheressian, GH Lyman, H Ozer, JO Armitage, L Balducci, ...
J Clin Oncol 24 (19), 3187-3205, 2006
14422006
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive …
EP Winer, C Hudis, HJ Burstein, AC Wolff, KI Pritchard, JN Ingle, ...
Journal of clinical oncology 23 (3), 619-629, 2005
10062005
Weekly paclitaxel in the adjuvant treatment of breast cancer
JA Sparano, M Wang, S Martino, V Jones, EA Perez, T Saphner, AC Wolff, ...
New England Journal of Medicine 358 (16), 1663-1671, 2008
9052008
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis
BB Barone, HC Yeh, CF Snyder, KS Peairs, KB Stein, RL Derr, AC Wolff, ...
Jama 300 (23), 2754-2764, 2008
7982008
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
S Adams, RJ Gray, S Demaria, L Goldstein, EA Perez, LN Shulman, ...
Journal of clinical oncology 32 (27), 2959, 2014
7852014
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting
JLWAC Khatcheressian, TJGE Smith, HBVVG Muss, FSMR Halberg, ...
Journal of Clinical Oncology 24 (31), 5091-5097, 2006
5952006
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
HJ Burstein, AD Elias, HS Rugo, MA Cobleigh, AC Wolff, PD Eisenberg, ...
Journal of Clinical Oncology 26 (11), 1810-1816, 2008
5832008
Adjuvant chemotherapy in older women with early-stage breast cancer
HB Muss, DA Berry, CT Cirrincione, M Theodoulou, AM Mauer, ...
New England Journal of Medicine 360 (20), 2055-2065, 2009
5262009
Breast cancer
RW Carlson, DC Allred, BO Anderson, HJ Burstein, WB Carter, SB Edge, ...
Journal of the National Comprehensive Cancer Network 7 (2), 122-192, 2009
5152009
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update
JL Khatcheressian, P Hurley, E Bantug, LJ Esserman, E Grunfeld, ...
J Clin Oncol [internet], 2012
5122012
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
SM Tolaney, WT Barry, CT Dang, DA Yardley, B Moy, PK Marcom, ...
New England Journal of Medicine 372 (2), 134-141, 2015
4822015
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer
LA Carey, HS Rugo, PK Marcom, EL Mayer, FJ Esteva, CX Ma, MC Liu, ...
Journal of clinical oncology 30 (21), 2615, 2012
4442012
Extending aromatase-inhibitor adjuvant therapy to 10 years
PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, ...
N Engl J Med 375, 209-219, 2016
4052016
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update
AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ...
Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018
3992018
Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis
KS Peairs, BB Barone, CF Snyder, HC Yeh, KB Stein, RL Derr, ...
Journal of Clinical Oncology 29 (1), 40, 2011
3702011
Detection of cancer DNA in plasma of patients with early-stage breast cancer
JA Beaver, D Jelovac, S Balukrishna, RL Cochran, S Croessmann, ...
Clinical cancer research 20 (10), 2643-2650, 2014
2842014
The system can't perform the operation now. Try again later.
Articles 1–20